| Biomarker ID | 1475 |
| PMID | 25075204 |
| Year | 2014 |
| Biomarker | PTEN + CCND1 +SMAD4 + SSP1 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Immune system, Disease, T cell receptor regulation of apoptosis, Adaptive immune system, TGF-beta regulation of extracellular matrix |
| Experiment | Lethal Outcome Vs No Lethal Outcome |
| Type of Biomarker | Prognostic |
| Cohort | 340 Prosteactomy samples were chosen in the cohort and divided into training and testing |
| Senstivity | NA |
| Specificity | NA |
| AUC | Cox Model: Training: 0.701; Testing: 0.747;Logistic Regression: Training: 0.693; Testing: 0.753 |
| Accuracy | NA |
| Level Of Significance | p = 0.00000456 |
| Method Used | Automated quantitative multiplex immunofluorescence in situ imaging |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |